So why did Tilray stock fall? Probably the most likely culprit was a general sell-off in Canadian marijuana stocks after analyst Graeme Kreindler with Eight Capital slashed his price target for Aphria (APHA) from $22 in Canadian dollars to CA$7 (from $16.50 to $5.24). Kreindler also changed his rating for Aphria from buy to neutral.
Why did Tilray (TLRY) stock fall 17% on Tuesday?
Feb 15, 2021 · GLJ Research analyst Gordon Johnson told investors to sell their shares of Tilray on Thursday -- and sell they did. Johnson didn't exactly mince words. He placed a $0 price forecast on Tilray's...
Is Tilray stock a good investment?
Mar 04, 2020 · Shares of Tilray ( TLRY ) had fallen 11.5% as of 11:03 a.m. EST on Tuesday. The drop resulted from the Canadian cannabis producer's disappointing fourth-quarter update after the market closed on...
Why is Tilray's sales slumping?
Nov 18, 2021 · In the analyst's opinion, Tilray is being priced too high for its potential growth. With the stock up 83% over the past year, investors may …
What happened to Tilray in Q4?
Jan 15, 2019 · Shares of Tilray TLRY fell more than 17% on Tuesday after its post-IPO lockup period expired, allowing early investors in the Canadian marijuana company to cash out of their positions for the first...
Will Tilray stock go up again?
That means that it is possible for Tilray to reach $4 billion in 2024 if its trajectory continues as it has. In other words, it doubles in 2022 to reach $1 billion in revenue. That $1 doubles again in 2023, reaching $2 billion, and then again in 2024 to hit the stated $4 billion goal.Jan 4, 2022
Should I sell my TLRY stock?
(TLRY-Q) Rating. Stockchase rating for Tilray Inc. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.
Who invested in Tilray?
Founded in 2014, Tilray was originally incorporated under the umbrella of Seattle-based Privateer Holdings and was one of Canada's first licensed producers. At the end of 2014, it secured the first institutional investment in the cannabis industry from Founders Fund, a San Francisco-based venture capital fund.
Will Tilray stock go up tomorrow?
Tomorrow's movement Prediction of Tilray, Inc. TLRY as on 08 Apr 2022 appears undecisive. It can be Bearish or Bullish. You should wait for the first half to take a decision on this stock....Munafa value: 44 as on 08 Fri Apr 2022.Downside target5.95Upside target6.76Upside target6.93Upside target7.396 more rows
What is the main problem with Tilray?
So what. The main problem for Tilray is that the trends aren't its friends. Both the top and bottom lines for the company are heading in the wrong direction. Tilray's primary issue on the top line is that its bulk cannabis revenue plunged nearly 61% from Q3.
Is Tilray stock volatile?
In addition, the company has cut costs significantly as part of a restructuring announced last month. Still, expect Tilray stock to remain highly volatile this year.
NASDAQ: TLRY
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
What happened
The stock market harshed marijuana investors ' buzz Thursday afternoon, as shares of Curaleaf Holdings ( CURLF -0.69% ) tumbled 4.5% in 12:25 p.m. ET trading, and Cronos Group ( CRON -6.86% ) and Tilray ( TLRY -4.77% ) fell even harder -- down 10.1% and 12.1%, respectively.
So what
Marijuana investors are digesting both macro and micro stories today, and the macro one is that in Washington, D.C., Senate Majority Leader Chuck Schumer just threw cold water on the idea that marijuana legalization will be good news for all participants in the industry.
NASDAQ: TLRY
Although Schumer has been hailed in some quarters as a hero for championing the 163-page Cannabis Administration and Opportunity Act that would finally legalize marijuana on the national level, he's being quoted today on MarijuanaMoment.net saying that he wants to hobble the titans of the marijuana industry in favor of smaller operators, and ensure "the big boys [don't] come in and make all the money.".
Now what
And the news gets even worse for investors in Cronos and Tilray. British banker Barclays chose today to initiate coverage of both Cronos and Tilray -- with underweight (i.e., sell) ratings.
Premium Investing Services
Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.
What is a tilray?
Tilray Inc ( NASDAQ:TLRY) is a leading global cannabis company with subsidiaries in North America, Europe, Latin America, Australia, and New Zealand. It has a portfolio of successful brands and a large footprint across the globe. Yet despite cannabis being largely listed as essential, Tilray’s stock took a pummeling in the aftermath ...
How much is the stock market cap in 2020?
This puts a double squeeze on it, which continues pummeling the stock price. As of October 2020, the market cap is now around $700 million. Share prices are just barely above OTC levels, and it dropped over 7x more than the S&P 500 in September.
How much did the Canadian dollar gain in the year?
The Canadian dollar strengthened over the U.S. dollar, which helped the company gain $13.3 million for the year. Still, it’s down to only $137.2 million in cash, with another $250 million it can access to spend when needed.
Does Tilray sell medical marijuana?
Although Tilray has sales in recreational cannabis, medical marijuana, and hemp, so it should be able to squeeze profits from all three. Still, investors are conversative about investing in Tilray and cannabis in general. This is putting a squeeze on its market cap.
How much did the company increase revenue in the second quarter of 2020?
Revenue in the second quarter of 2020 (reported August 2020) showed the company increased revenue by 10 percent over the same quarter of 2019 to $50.4 million. Of course, that didn’t stop it from experiencing an $81.7 million loss, which was largely due to inventory adjustment.
Is it easy to make ends meet in the marijuana market?
Making ends meet in the wholesale marijuana market isn’t easy, and margins are razor thin (assuming you can find a buyer when the market reaches a surplus, which is exactly what happened in Canada in its first two years of legalization). Free Stock Tools - Financhill. Close. Yes. No.
This Is Still A Bullish Market
In spite of growing concerns, the current macroeconomic scenario still favors the bulls. Don’t take my word for it, just check the action in the charts. They say “price is truth,” and so far the major indices go from lower left to upper right.
Own TLRY Stock for the Long Term
Near $10 per share, TLRY makes for a an intriguing long-term thesis. The whole sector moves pretty fast and in both directions. Therefore, this is not an appropriate stock for all investors. Not everyone has the intestinal fortitude to withstand such volatility.